Search results for "Clero"
showing 10 items of 2052 documents
Association between resting blood pressure and maximal blood pressure response to exercise and arterial health
2022
We investigated the longitudinal associations of blood pressure, cardiorespiratory fitness, and arterial stiffness among children. Arterial stiffening has been repeatedly shown to be a cardiovascular mortality predictor and can be observed early in childhood. As such, it is crucial to understand whether a child’s blood pressure, fitness level, and body composition can predict early signs of atherosclerosis and arterial stiffening. The current study examined the relationship between blood pressure, cardiorespiratory fitness, and arterial stiffness over time in children, using data from the Physical and Nutrition in Children (PANIC) Study. It is a physical and dietary intervention study condu…
La diagnosi precoce della sclerosi sistemica progressiva
2002
BACKGROUND: The study considers the oro-facial manifestations occurring in a group of patients suffering from progressive systemic sclerosis, evaluating their predictive role and monitoring the systemic disease. METHODS: 34 patients with systemic sclerosis were examining: 30 women, 4 men, at the Department of Dental Sciences, Palermo University, from July 1998 to March 2001. All patients were positive for the diagnostic criteria of scleroderma.1 For each patient we considered: observation of any changes in soft tissues of the oral cavity; evaluation of possible xerostomia; evaluation of any fungal infections; presence of prosthetic sores in patients wearing dentures; DMFS evaluation; evalua…
SYSTEMIC SCLEROSIS:DESCRIPTION AND DIAGNOSTIC ROLE OF ORAL PHENOMENA
2004
This study was designed to describe and evaluate the eventual prodromic role of the orofacial phenomena encountered in patients suffering from systemic sclerosis. Phenomena preceding the diagnosis and events that occured at the onset of systemic sclerosis were considered. Sclerodermic patients were monitored to implement a secondary preventive plan for controlling oral injuries caused by developing systemic sclerosis.
Terapia Celular en Enfermedades Desmielinizantes
2021
Antecedentes y estado actual del tema: La Esclerosis Múltiple es una enfermedad autoinmune y neurodegenerativa crónica de base inflamatoria que afecta a la sustancia gris y blanca del sistema nervioso central. Se caracteriza por la presencia de lesiones focales desmielinizantes y afectación difusa del tejido nervioso aparentemente normal, siendo la discapacidad consecuencia de la neurodegeneración progresiva, a la que se superpone la discapacidad que pueda aparecer como consecuencia de un brote. Los llamados tratamientos modificadores de la Esclerosis Múltiple limitan los brotes de inflamación que acontecen en la forma remitente-recurrente pero apenas modifican la progresión de la discapaci…
Wytyczne PTL/KLRWP/PTK/PTDL/PTD/PTNT diagnostyki i leczenia zaburzeń lipidowych w Polsce 2021
2021
The Effects of Transcutaneous Spinal Direct Current Stimulation on Neuropathic Pain in Multiple Sclerosis: Clinical and Neurophysiological Assessment
2019
Background: Central neuropathic pain represents one of the most common symptoms in multiple sclerosis (MS) and it seriously affects quality of life. Spinal mechanisms may contribute to the pathogenesis of neuropathic pain in MS. Converging evidence from animal models and neurophysiological and clinical studies in humans suggests a potential effect of transcranial direct current stimulation (tc-DCS) on neuropathic pain. Spinal application of DCS, i.e., transcutaneous spinal DCS (ts-DCS), may modulate nociception through inhibition of spinal reflexes. Therefore, ts-DCS could represents an effective, safe and well-tolerated treatment for neuropathic pain in MS, a largely unexplored topic. This…
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial
2022
Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options. RNS60 is an immunomodulatory and neuroprotective investigational product that has shown efficacy in animal models of ALS and other neurodegenerative diseases. Its administration has been safe and well tolerated in ALS subjects in previous early phase trials. Methods: This was a phase II, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial. Participants diagnosed with definite, probable or probable laboratory-supported ALS were assigned to receive RNS60 or placebo administered for 24 weeks intravenously (375 ml) once a week and via nebul…
Digital ulcer, Raynaud phenomenon and osteomyelitis of the fifth finger in patient with systemic sclerosis: personal experience
2012
Estudi clínic,neuropsicològic i de Ressonància magnètica de l´Esclerosi Múltiple primària progressiva
2015
L´esclerosi múltiple primària progressiva es presenta entre un 10-15 % dels pacients, ve definida per un curs progressiu sense brots clars i amb una presentació típica en forma de paraparèsia espàstica fins en un 80 % dels casos. No disposa de tractament aprovat modificador de la malaltia en l´actualitat si bé s´ha vist en base a estudis d´inflamació en LCR que podria existir un subgrup que tindrien un perfil clínic diferent amb inflamació i es podrien beneficiar de tractament. Es tracta doncs, d’un subtipus d’ EM que suposa un repte per a la pràctica clínica, caracteritzat per la progressió inevitable de la discapacitat. És per això que el nostre estudi es va basar en explorar el patró clí…